Phase I Study of Multiple Epitope Peptide Vaccination in Patients With Recurrent or Persistent Cervical Cancer.

Phase I Study of Multiple Epitope Peptide Vaccination in Patients With Recurrent or Persistent Cervical Cancer. J Immunother. 2018 May; 41(4):201-207.

View in: PubMed

subject areas

Adult
Aged
Cancer Vaccines
Epitopes
Female
Humans
Immunotherapy
Magnetic Resonance Imaging
Middle Aged
T-Lymphocytes
T-Lymphocytes, Cytotoxic
Treatment Outcome
Uterine Cervical Neoplasms
Vaccination
Vaccines, Subunit

authors with profiles

Yusuke Nakamura